While research on crop species is being increasingly promoted, redox interactions are fundamental to the development and acclimation of all plants, and their elucidation is likely to be favoured by continued research on model systems
Most people who look into it have already spent years trying to eat better, stay active, and do the right things but still feel like progress is harder than it should be
In Phase 2 studies, it led to a bigger average weight drop (about 24%) than Tirzepatide (about 21%)
Nitric-oxide (NO), VEGF/VEGFR2, and FAK-paxillin pathway activity in cell-culture models of soft-tissue repair using BPC-157
This timeline is substantially longer than how quickly prescription GLP-1 medications work

Metabolic Syndrome Resolution Post-hoc analysis of SURPASS trials demonstrated substantial reductions in metabolic syndrome prevalence: Significant improvements in multiple cardiovascular risk factors simultaneously Reductions in blood pressure, improved lipid profiles, and decreased waist circumference Resolution of metabolic syndrome criteria in a substantial proportion of participants Potential long-term cardiovascular benefits from comprehensive metabolic improvements Cardiovascular and Metabolic Comorbidities Heart Failure with Preserved Ejection Fraction (HFpEF) The SUMMIT phase 3 trial evaluated GLP2 in adults with HFpEF and obesity: Statistically significant reduction in heart failure outcomes (composite endpoint) Improvements in heart failure symptoms and physical limitations measured by Kansas City Cardiomyopathy Questionnaire Enhanced exercise capacity as measured by 6-Minute Walk Test Distance Reduction in high-sensitivity C-reactive protein (inflammation marker) These findings established GLP2 as the first incretin therapy to demonstrate benefits on heart failure outcomes in this population
